Researchers discover that activating innate immunity in the gastrointestinal tract reduces disease pathology in ulcerative colitis
01 oct. 2018 07h00 HE
|
Qu Biologics, Inc.
VANCOUVER, British Columbia, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of...
INmune Bio Named Finalist for Lifestars’ U.S. Private Company of the Year Award
27 sept. 2018 08h30 HE
|
INmune Bio, Inc.
Recognized for big strides in cancer immunotherapy treatments LA JOLLA, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) -- via NetworkWire -- INmune Bio Inc., an immunotherapy company developing treatments...
BriaCell Therapeutics Corp. Discusses its Plan to Revolutionize Cancer Immunotherapy in Exclusive NetworkNewsWire Audio Interview
25 sept. 2018 06h30 HE
|
NetworkNewsWire
NEW YORK, Sept. 25, 2018 (GLOBE NEWSWIRE) -- via NetworkWire - NetworkNewsAudio (NNA), a NetworkNewsWire (NNW) Solution that delivers clients unparalleled visibility, recognition and brand awareness...
Cidara Therapeutics to Present at Two Upcoming Investor Conferences
24 sept. 2018 16h05 HE
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
Coverage Initiated for BriaCell Therapeutics Corp. via NetworkNewsWire
21 sept. 2018 08h30 HE
|
NetworkNewsWire
NEW YORK, Sept. 21, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – BriaCell Therapeutics Corp. (OTCQB: BCTXF; TSX: BCT.V) (BriaCell or the Company), an immuno-oncology focused biotechnology company with...
Todos Medical, Ltd. Signs Non-Binding Memorandum of Understanding with Orot+ for Distribution Rights of its Breast Cancer Screening Tests in Romania and Austria
13 sept. 2018 08h30 HE
|
Todos Medical Ltd.
REHOVOT, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
13 sept. 2018 08h00 HE
|
Crown Bioscience
SAN DIEGO, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
INmune Bio Co-Founder and Chief Scientific Officer Mark Lowdell, Ph.D., Chairing Sessions at International Society of Cell and Gene Therapy (ISCT) European Regional Meeting
12 sept. 2018 18h47 HE
|
INmune Bio, Inc.
LA JOLLA, Calif. , Sept. 12, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – INmune Bio, Inc., an immunotherapy company developing treatments to reprogram the patient’s innate immune system, today...
TrakCel to develop and supply Medeor Therapeutics with cellular supply chain management and orchestration system
12 sept. 2018 08h00 HE
|
TrakCel
CARDIFF, United Kingdom, Sept. 12, 2018 (GLOBE NEWSWIRE) -- TrakCel, the cell and gene therapy supply chain tracking and orchestration system software developer, today announces it has been engaged...
CCAB and Triumvira Immunologics Announce Triumvira’s License Agreement with University of Toronto for the Discovery of Antibody Drug Development Candidates
10 sept. 2018 09h00 HE
|
Centre for the Commercialization of Antibodies and Biologics
AUSTIN, Texas and HAMILTON, Ontario and TORONTO, Sept. 10, 2018 (GLOBE NEWSWIRE) -- The Centre for the Commercialization of Antibodies and Biologics (CCAB) and Triumvira Immunologics, Inc....